ALDH1A3 and prostate adenocarcinoma: To investigate the predictive value of ALDH1A1 and ALDH1A3 gene expression, we analyzed biochemical recurrence-free survival (BRFS) of TCGA PRAD patients' cohort stratified based on the expression of those two genes.